by Peter Murray: A clinical trial testing a gene
therapy for HIV patients is now 11 years old. Recently, the researchers
running the study published an examination of the patients after all
this time. Of the study’s 43 patients, all were healthy, and
41 of them confirmed that their immune cells which received a
genetically-altered boost were still performing as hoped more than a
decade after the initial infusions.
Researchers first collected some of the patients’ T cells,
the type of white blood cell that fights infections and tumors. They
then added a retroviral vector to the cells that inserted its DNA into
the cells’ own...